fluorodeoxyglucose f18 has been researched along with Nerve Degeneration in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (26.92) | 18.2507 |
| 2000's | 12 (46.15) | 29.6817 |
| 2010's | 7 (26.92) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crivellaro, C; Ferrarese, C; Ferri, F; Grisanti, SG; Isella, V; Morzenti, S; Musarra, M | 1 |
| Benvenutto, A; Ceccaldi, M; Didic, M; Felician, O; Giusiano, B; Guedj, E; Gueriot, C; Guye, M; Koric, L | 1 |
| Bakardjian, H; Corsi, MC; De Vico Fallani, F; Diego Sitt, J; Dubois, B; Epelbaum, S; Gagliardi, G; Gaubert, S; Habert, MO; Hermann, B; Houot, M; Naccache, L; Oudiette, D; Raimondo, F | 1 |
| Chen, Y; Cui, Y; Guan, Z; Jiang, C; Lei, R; Liu, H; Wang, A; Wang, Z; Wu, X; Xia, T; Yang, L; Yu, L; Zeng, Q; Zhang, C; Zhang, S; Zhang, X | 1 |
| Al-Sayed, AA; Bascuñana, P; Bermejo-Bescós, P; Delgado, M; Fernández de la Rosa, R; García-García, L; Martín-Aragón, S; Pozo, MA | 1 |
| Calsolaro, V; Edison, P | 1 |
| Araie, M; Hara, H; Imamura, K; Kato, K; Mizuma, H; Nakajima, H; Nozaki, S; Onoe, H; Onoe, K; Sasaoka, M; Shimazawa, M; Tanaka, S; Taniguchi, T; Wada, Y; Watanabe, Y | 1 |
| Aresi, A; Bizzi, A; Giovagnoli, AR; Gobbo, C; Reati, F; Riva, A | 1 |
| Schwarz, J | 1 |
| Alexander, GE; Hampel, H; Möller, HJ; Pogarell, O; Rapoport, SI; Teipel, SJ | 1 |
| Csornai, M; Esik, O; Lengyel, Z; Lesznyák, J; Majtényi, K; Pisch, J; Rékó, G; Trón, L | 1 |
| Hajak, G; Ibach, B; Männer, P; Marienhagen, J; Poljansky, S; Sommer, M | 1 |
| Barnes, A; Dhawan, V; Eckert, T; Eidelberg, D; Feigin, AS; Frucht, S; Gordon, MF | 1 |
| Arzberger, T; Becker, G; Berg, D; Gerlach, M; Musicco, M; Rausch, WD; Riederer, P; Ruprecht, P; Tampellini, D; Zecca, L | 1 |
| Leenders, KL; Maguire, RP; Pruim, J; Roos, RA; van Oostrom, JC; Veenma-van der Duin, L; Verschuuren-Bemelmans, CC | 1 |
| Brooks, DJ; Hajnal, JV; Hu, MT; Khan, NL; Lees, AJ; Quinn, N; Scherfler, C; Wood, NW | 1 |
| Linden, DE; Maurer, K; Prvulovic, D; Sack, AT; Van de Ven, V | 1 |
| Fujiwara, T; Ido, T; Itoh, M; Itoyama, Y; Iwata, R; Kimura, I; Nagasawa, H; Nomura, H; Saito, H; Tanji, H; Tuji, S | 1 |
| Chugani, HT; da Silva, E; Philippart, M | 1 |
| Ghaemi, M; Haupt, WF; Heiss, WD; Rudolf, J; Szelies, B | 1 |
| Bacher-Stier, C; Donnemiller, E; Erler, H; Moncayo, R; Oberladstätter, M; Riccabona, G; Zaknun, J | 1 |
| Degueldre, C; Franck, G; Garraux, G; Laureys, S; Lemaire, C; Peigneux, P; Salmon, E | 1 |
| Al-Essa, MA; Bakheet, SM; Ozand, PT; Patay, ZJ; Powe, JE | 1 |
| Araujo, DM; Cherry, SR; Kornblum, HI; Tatsukawa, KJ; Toyokuni, T | 1 |
| Agid, Y; Blin, J; Dubois, B; Feve, JR; Pillon, B; Vidailhet, MJ | 1 |
| Cederbaum, J; Dhawan, V; Eidelberg, D; Fahn, S; Ginos, JZ; Greene, P; Moeller, JR; Powers, JM; Sidtis, JJ; Strother, SC | 1 |
3 review(s) available for fluorodeoxyglucose f18 and Nerve Degeneration
| Article | Year |
|---|---|
Alterations in Glucose Metabolism in Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Biomarkers; Blood Glucose; Brain; Diabetes Mellitus, Type 2; Drug Discovery; Fluorodeoxyglucose F18; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Nerve Degeneration; Neuroprotective Agents; Patents as Topic; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors | 2016 |
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update].
Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Nerve Degeneration; Neurons; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Dopamine; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2010 |
Functional activation imaging in aging and dementia.
Topics: Aged; Aging; Alzheimer Disease; Brain; Cerebrovascular Circulation; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Nerve Degeneration; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals | 2005 |
2 trial(s) available for fluorodeoxyglucose f18 and Nerve Degeneration
| Article | Year |
|---|---|
Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease.
Topics: Age of Onset; Aged; Alzheimer Disease; Aphasia, Primary Progressive; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Lobe | 2004 |
One year's clinical experience of 18F-FDG PET with a modified SPET camera using molecular coincidence detection.
Topics: Coronary Disease; Epilepsy; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Neoplasms; Nerve Degeneration; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 1999 |
21 other study(ies) available for fluorodeoxyglucose f18 and Nerve Degeneration
| Article | Year |
|---|---|
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration.
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Cognitive Reserve; Female; Fluorodeoxyglucose F18; Humans; Male; Nerve Degeneration; Positron-Emission Tomography | 2018 |
Imaging Biomarkers of Neurodegeneration in Alzheimer's Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Degeneration; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2018 |
EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain Waves; Case-Control Studies; Disease Progression; Electroencephalography; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Nerve Degeneration; Positron-Emission Tomography; Prodromal Symptoms | 2019 |
Low glucose utilization and neurodegenerative changes caused by sodium fluoride exposure in rat's developmental brain.
Topics: Animals; Body Weight; Brain; Brain-Derived Neurotrophic Factor; CA1 Region, Hippocampal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glucose; Glucose Transporter Type 1; Learning Disabilities; Magnetic Resonance Imaging; Male; Maze Learning; Memory Disorders; Multimodal Imaging; Nerve Degeneration; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Rats; Rats, Sprague-Dawley; Sodium Fluoride; Tomography, X-Ray Computed | 2014 |
In vivo [¹⁸F] FDG PET imaging reveals that p-chloroamphetamine neurotoxicity is associated with long-term cortical and hippocampal hypometabolism.
Topics: Animals; Autoradiography; Fluoresceins; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Glucose; Hippocampus; Immunohistochemistry; Indoles; Male; Nerve Degeneration; Neurotoxins; p-Chloroamphetamine; Positron-Emission Tomography; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins | 2015 |
Molecular imaging reveals unique degenerative changes in experimental glaucoma.
Topics: Animals; Carbon Radioisotopes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Geniculate Bodies; Glaucoma; Haplorhini; Immunohistochemistry; Isoquinolines; Microglia; Nerve Degeneration; Occipital Lobe; Ophthalmoscopes; Positron-Emission Tomography; Visual Cortex | 2009 |
The neuropsychological and neuroradiological correlates of slowly progressive visual agnosia.
Topics: Agnosia; Aspartic Acid; Atrophy; Brain; Brain Mapping; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe | 2009 |
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and
Topics: Alzheimer Disease; Atrophy; Corpus Callosum; Disease Progression; Electroencephalography; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Neocortex; Nerve Degeneration; Neurons; Radiography; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2002 |
Autopsy verifies demyelination and lack of vascular damage in partially reversible radiation myelopathy.
Topics: Adult; Autopsy; Blood Vessels; Cervical Vertebrae; Demyelinating Diseases; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Medulla Oblongata; Meningitis; Methionine; Nerve Degeneration; Neurons; Oxygen Radioisotopes; Paraplegia; Radiation Injuries; Radiography; Radiotherapy; Spinal Cord; Spinal Cord Diseases; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
FDG PET in the differential diagnosis of parkinsonian disorders.
Topics: Aged; Aging; Brain; Brain Mapping; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive | 2005 |
In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
Topics: Apoferritins; Early Diagnosis; Female; Ferritins; Fluorodeoxyglucose F18; Humans; Iron; Male; Melanins; Middle Aged; Nerve Degeneration; Parkinson Disease; Radiopharmaceuticals; Substantia Nigra; Ultrasonography, Doppler, Transcranial | 2005 |
Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease.
Topics: Adult; Binding, Competitive; Biomarkers; Corpus Striatum; Disease Progression; DNA Mutational Analysis; Dopamine; Dopamine Antagonists; Female; Fluorodeoxyglucose F18; Glucose; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Nuclear Proteins; Positron-Emission Tomography; Predictive Value of Tests; Raclopride; Receptors, Dopamine D2; Trinucleotide Repeat Expansion | 2005 |
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.
Topics: Adult; Caudate Nucleus; Corpus Striatum; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Point Mutation; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Substantia Nigra; Ubiquitin-Protein Ligases | 2006 |
PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
Topics: Aged; Apraxias; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Diseases; Cerebral Cortex; Cerebrovascular Circulation; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Tomography, Emission-Computed | 1996 |
The value of positron emission tomography in the diagnosis and monitoring of late infantile and juvenile lipopigment storage disorders (so-called Batten or neuronal ceroid lipofuscinoses).
Topics: Blood Glucose; Brain; Brain Mapping; Child; Child, Preschool; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Nerve Degeneration; Neuronal Ceroid-Lipofuscinoses; Tomography, Emission-Computed; Tripeptidyl-Peptidase 1 | 1997 |
Cerebral glucose metabolism in acute and persistent vegetative state.
Topics: Activities of Daily Living; Adolescent; Adult; Age Factors; Aged; Brain; Case-Control Studies; Cerebellum; Cerebral Cortex; Consciousness; Electroencephalography; Evoked Potentials, Somatosensory; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Glucose; Heart Arrest; Humans; Hypoxia, Brain; Male; Middle Aged; Nerve Degeneration; Persistent Vegetative State; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 1999 |
Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration.
Topics: Aged; Basal Ganglia; Brain Diseases; Cerebral Cortex; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Radiopharmaceuticals; Reference Values; Tissue Distribution; Tomography, Emission-Computed | 1999 |
Clinical and cerebral FDG PET scan in a patient with Krabbe's disease.
Topics: Child, Preschool; Fluorodeoxyglucose F18; Humans; Leukodystrophy, Globoid Cell; Male; Nerve Degeneration; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
Topics: Animals; Autoradiography; Benzazepines; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Energy Metabolism; Female; Fluorodeoxyglucose F18; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Huntington Disease; In Situ Hybridization; Nerve Degeneration; Neurotoxins; Quinolinic Acid; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Spiperone; Substantia Nigra; Tomography, Emission-Computed; Tritium | 2000 |
Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.
Topics: Aged; Apraxias; Blood Glucose; Brain Mapping; Cerebral Cortex; Corpus Striatum; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Nerve Degeneration; Substantia Nigra; Thalamic Nuclei; Tomography, Emission-Computed | 1992 |
The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Topics: Aged; Apraxias; Basal Ganglia Diseases; Blood Glucose; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Muscle Rigidity; Nerve Degeneration; Neurologic Examination; Parkinson Disease, Secondary; Pyramidal Tracts; Tomography, Emission-Computed; Tremor | 1991 |